HealthEquity (NASDAQ:HQY) Raised to “Buy” at Wall Street Zen

HealthEquity (NASDAQ:HQY) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.

A number of other equities analysts also recently commented on the company. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Citizens Jmp boosted their price objective on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. Citigroup restated a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Finally, BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $85.00 to $105.00 in a research report on Thursday, April 9th. Eleven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.93.

HealthEquity Stock Performance

HQY opened at $94.64 on Friday. HealthEquity has a 12-month low of $72.76 and a 12-month high of $105.96. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The stock has a market capitalization of $7.91 billion, a PE ratio of 35.45, a P/E/G ratio of 1.59 and a beta of 0.21. The firm’s fifty day moving average price is $90.21 and its 200 day moving average price is $84.88.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. The company had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, research analysts expect that HealthEquity will post 3.92 EPS for the current fiscal year.

Insider Transactions at HealthEquity

In other news, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. The trade was a 11.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the sale, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. This represents a 5.05% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On HealthEquity

Several institutional investors have recently made changes to their positions in HQY. Acumen Wealth Advisors LLC bought a new stake in shares of HealthEquity in the 4th quarter worth approximately $27,000. Aster Capital Management DIFC Ltd bought a new position in HealthEquity during the 4th quarter worth $28,000. Caitong International Asset Management Co. Ltd grew its stake in HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares during the last quarter. Leonteq Securities AG increased its position in HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after buying an additional 235 shares during the period. Finally, Axiom Investment Management LLC acquired a new stake in HealthEquity in the first quarter worth $33,000. 99.55% of the stock is owned by institutional investors.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.